[{"headers": [["Condensed Consolidated Balance Sheets - USD ($) $ in Millions", "Apr. 30, 2020", "Jan. 31, 2020"]], "sections": ["Current assets:", "Current liabilities:", "Stockholders\u2019 equity:"], "data": [["Cash and cash equivalents", "$ 5,772", "$ 4,145"], ["Marketable securities", "4,030", "3,802"], ["Accounts receivable, net", "3,076", "6,174"], ["Costs capitalized to obtain revenue contracts, net", "881", "926"], ["Prepaid expenses and other current assets", "954", "916"], ["Total current assets", "14,713", "15,963"], ["Property and equipment, net", "2,518", "2,375"], ["Operating lease right-of-use assets, net", "2,983", "3,040"], ["Noncurrent costs capitalized to obtain revenue contracts, net", "1,171", "1,348"], ["Strategic investments", "1,902", "1,963"], ["Goodwill", "25,266", "25,134"], ["Intangible assets acquired through business combinations, net", "4,488", "4,724"], ["Capitalized software and other assets, net", "582", "579"], ["Total assets", "53,623", "55,126"], ["Accounts payable, accrued expenses and other liabilities", "2,989", "3,433"], ["Operating lease liabilities, current", "742", "750"], ["Unearned revenue", "9,112", "10,662"], ["Total current liabilities", "12,843", "14,845"], ["Noncurrent debt", "2,673", "2,673"], ["Noncurrent operating lease liabilities", "2,422", "2,445"], ["Other noncurrent liabilities", "1,120", "1,278"], ["Total liabilities", "19,058", "21,241"], ["Common stock", "1", "1"], ["Additional paid-in capital", "32,739", "32,116"], ["Accumulated other comprehensive\u00a0loss", "(135)", "(93)"], ["Retained earnings", "1,960", "1,861"], ["Total stockholders\u2019 equity", "34,565", "33,885"], ["Total liabilities and stockholders\u2019 equity", "$ 53,623", "$ 55,126"]]}, {"headers": [["Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions", "3 Months Ended"], ["Apr. 30, 2020", "Apr. 30, 2019"]], "sections": ["Revenues:", "Cost of revenues:", "Operating expenses:", "Revenues:", "Cost of revenues:", "Revenues:", "Cost of revenues:"], "data": [["Total revenues", "", "$ 4,865", "$ 3,737"], ["Total cost of revenues", "[1],[2]", "1,254", "914"], ["Gross profit", "", "3,611", "2,823"], ["Research and development", "[1],[2]", "859", "554"], ["Marketing and sales", "[1],[2]", "2,390", "1,697"], ["General and administrative", "[1],[2]", "502", "362"], ["Total operating expenses", "[1],[2]", "3,751", "2,613"], ["Income (loss) from operations", "", "(140)", "210"], ["Gains on strategic investments, net", "", "192", "281"], ["Other expense", "", "(5)", "(9)"], ["Income before benefit from (provision for) income taxes", "", "47", "482"], ["Benefit from (provision for) income taxes", "", "52", "(90)"], ["Net income", "", "$ 99", "$ 392"], ["Basic net income per share (in dollars per share)", "", "$ 0.11", "$ 0.51"], ["Diluted net income per share (in dollars per share)", "", "$ 0.11", "$ 0.49"], ["Shares used in computing basic net income per share (in shares)", "", "896", "771"], ["Shares used in computing diluted net income per share (in shares)", "", "913", "793"], ["Subscription and support", "", "", ""], ["Total revenues", "", "$ 4,575", "$ 3,496"], ["Total cost of revenues", "[1],[2]", "966", "678"], ["Professional services and other", "", "", ""], ["Total revenues", "", "290", "241"], ["Total cost of revenues", "[1],[2]", "$ 288", "$ 236"], [""], ["[1]\nAmounts include amortization of intangible assets acquired through business combinations, as follows:\u00a0Three Months Ended April 30,\u00a020202019Cost of revenues$159\u00a0$61\u00a0Marketing and sales112\u00a068\u00a0\n\n[2]\nAmounts include stock-based expense, as follows:\u00a0Three Months Ended April 30,\u00a020202019Cost of revenues$52\u00a0$43\u00a0Research and development166\u00a081\u00a0Marketing and sales223\u00a0177\u00a0General and administrative63\u00a042", "[1]", "Amounts include amortization of intangible assets acquired through business combinations, as follows:\u00a0Three Months Ended April 30,\u00a020202019Cost of revenues$159\u00a0$61\u00a0Marketing and sales112\u00a068", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Three Months Ended April 30,", "", "", "", "", "", "2020", "", "2019", "", "", "Cost of revenues", "", "", "", "", "$", "159", "", "", "$", "61", "", "", "", "Marketing and sales", "", "", "", "", "112", "", "", "68", "", "", "", "", "", "", "", "", "", "", "", "", "", "[2]", "Amounts include stock-based expense, as follows:\u00a0Three Months Ended April 30,\u00a020202019Cost of revenues$52\u00a0$43\u00a0Research and development166\u00a081\u00a0Marketing and sales223\u00a0177\u00a0General and administrative63\u00a042", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Three Months Ended April 30,", "", "", "", "", "", "2020", "", "2019", "", "", "Cost of revenues", "", "", "", "", "$", "52", "", "", "$", "43", "", "", "", "Research and development", "", "", "", "", "166", "", "", "81", "", "", "", "Marketing and sales", "", "", "", "", "223", "", "", "177", "", "", "", "General and administrative", "", "", "", "", "63", "", "", "42", "", "", ""], ["[1]", "Amounts include amortization of intangible assets acquired through business combinations, as follows:\u00a0Three Months Ended April 30,\u00a020202019Cost of revenues$159\u00a0$61\u00a0Marketing and sales112\u00a068", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Three Months Ended April 30,", "", "", "", "", "", "2020", "", "2019", "", "", "Cost of revenues", "", "", "", "", "$", "159", "", "", "$", "61", "", "", "", "Marketing and sales", "", "", "", "", "112", "", "", "68", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["", "", "", "Three Months Ended April 30,"], ["", "", "", "", "", "2020", "", "2019", "", ""], ["Cost of revenues", "", "", "", "", "$", "159", "", "", "$", "61", "", "", ""], ["Marketing and sales", "", "", "", "", "112", "", "", "68", "", "", ""], ["", "", "", "", "", "", "", "", "", ""], ["[2]", "Amounts include stock-based expense, as follows:\u00a0Three Months Ended April 30,\u00a020202019Cost of revenues$52\u00a0$43\u00a0Research and development166\u00a081\u00a0Marketing and sales223\u00a0177\u00a0General and administrative63\u00a042", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Three Months Ended April 30,", "", "", "", "", "", "2020", "", "2019", "", "", "Cost of revenues", "", "", "", "", "$", "52", "", "", "$", "43", "", "", "", "Research and development", "", "", "", "", "166", "", "", "81", "", "", "", "Marketing and sales", "", "", "", "", "223", "", "", "177", "", "", "", "General and administrative", "", "", "", "", "63", "", "", "42", "", "", ""], ["", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["", "", "", "Three Months Ended April 30,"], ["", "", "", "", "", "2020", "", "2019", "", ""], ["Cost of revenues", "", "", "", "", "$", "52", "", "", "$", "43", "", "", ""], ["Research and development", "", "", "", "", "166", "", "", "81", "", "", ""], ["Marketing and sales", "", "", "", "", "223", "", "", "177", "", "", ""], ["General and administrative", "", "", "", "", "63", "", "", "42", "", "", ""]]}, {"headers": [["Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions", "3 Months Ended"], ["Apr. 30, 2020", "Apr. 30, 2019"]], "sections": ["Operating activities:", "Adjustments to reconcile net income to net cash provided by operating activities:", "Changes in assets and liabilities, net of business combinations:", "Investing activities:", "Financing activities:", "Cash paid during the period for:"], "data": [["Net income", "$ 99", "$ 392"], ["Depreciation and amortization", "658", "437"], ["Amortization of costs capitalized to obtain revenue contracts, net", "247", "209"], ["Expenses related to employee stock plans", "504", "343"], ["Gains on strategic investments, net", "(192)", "(281)"], ["Accounts receivable, net", "3,094", "2,774"], ["Costs capitalized to obtain revenue contracts, net", "(25)", "(124)"], ["Prepaid expenses and other current assets and other assets", "(11)", "(97)"], ["Accounts payable", "147", "15"], ["Accrued expenses and other liabilities", "(904)", "(560)"], ["Operating lease liabilities", "(203)", "(164)"], ["Unearned revenue", "(1,555)", "(979)"], ["Net cash provided by operating activities", "1,859", "1,965"], ["Business combinations, net of cash acquired", "(103)", "(10)"], ["Purchases of strategic investments", "(342)", "(159)"], ["Sales of strategic investments", "601", "194"], ["Purchases of marketable securities", "(834)", "(734)"], ["Sales of marketable securities", "337", "86"], ["Maturities of marketable securities", "227", "56"], ["Capital expenditures", "(323)", "(159)"], ["Net cash used in investing activities", "(437)", "(726)"], ["Proceeds from employee stock plans", "258", "219"], ["Principal payments on financing obligations", "(48)", "(11)"], ["Repayments of debt", "(1)", "(1)"], ["Net cash provided by financing activities", "209", "207"], ["Effect of exchange rate changes", "(4)", "(5)"], ["Net increase in cash and cash equivalents", "1,627", "1,441"], ["Cash and cash equivalents, beginning of period", "4,145", "2,669"], ["Cash and cash equivalents, end of period", "5,772", "4,110"], ["Interest", "46", "50"], ["Income taxes, net of tax refunds", "$ 58", "$ 18"]]}, {"headers": [["Stockholders' Equity", "3 Months Ended"], ["Apr. 30, 2020"]], "sections": ["Equity [Abstract]"], "data": [["Stockholders' Equity", "Stockholders\u2019 EquityThe fair value of the Company\u2019s stock options and ESPP shares was estimated on the date of grant and the first day of the ESPP purchase period, respectively, using Black-Scholes option pricing model. The weighted-average fair value per share for stock options grants, excluding assumed awards, was $39.67 and $40.82 in the three months ended April 30, 2020 and 2019, respectively.ESPP assumptions and the related fair value per share table are disclosed in the three month period in which there is ESPP activity, such as an ESPP purchase. The Company's ESPP allows for two purchases during the fiscal year, one during the second quarter and one during the fourth quarter. The estimated life of the ESPP will be based on the two purchase periods within each offering period. The weighted-average fair value per share for ESPP shares was $41.76 in the three months ended April 30, 2020.Stock option activity, excluding the ESPP for the three months ended April 30, 2020 is as follows:\u00a0Options Outstanding\u00a0OutstandingStockOptions(in millions)Weighted-AverageExercise\u00a0PriceAggregateIntrinsic Value (in millions)Balance as of January 31, 202027\u00a0$98.56\u00a0Options granted under all plans6\u00a0154.23\u00a0Exercised(2)62.67\u00a0Balance as of April 30, 202031\u00a0$111.82\u00a0$1,542\u00a0Vested or expected to vest28\u00a0$108.78\u00a0$1,509\u00a0Exercisable as of April 30, 202014\u00a0$77.73\u00a0$1,201\u00a0The following table summarizes information about stock options outstanding as of April 30, 2020:\u00a0Options OutstandingOptions ExercisableRange of ExercisePricesNumberOutstanding(in millions)Weighted-AverageRemainingContractual\u00a0Life(Years)Weighted-AverageExercisePriceNumber ofShares(in millions)Weighted-AverageExercisePrice$0.36 to $59.347\u00a02.9$40.47\u00a06\u00a0$41.91\u00a0$59.37 to $80.995\u00a03.477.03\u00a04\u00a077.85\u00a0$81.02 to $118.045\u00a04.8114.30\u00a02\u00a0113.29\u00a0$122.03 to $148.952\u00a06.0142.32\u00a00\u00a00.00\u00a0$154.14 6\u00a07.0154.14\u00a00\u00a00.00\u00a0$155.20 to $189.506\u00a05.8161.90\u00a02\u00a0161.50\u00a031\u00a04.9$111.82\u00a014\u00a0$77.73\u00a0Restricted stock activity for the three months ended April 30, 2020 is as follows:\u00a0Restricted Stock\u00a0Outstanding\u00a0Outstanding(in millions)Weighted-Average Grant Date Fair ValueAggregateIntrinsicValue (in millions)Balance as of January 31, 202028\u00a0$140.14\u00a0Granted - restricted stock units and awards9\u00a0155.92\u00a0Granted - performance-based stock units1\u00a0154.14\u00a0Canceled(1)138.87\u00a0Vested and converted to shares(4)135.70\u00a0Balance as of April 30, 202033\u00a0$142.71\u00a0$5,428\u00a0Expected to vest29\u00a0$4,654\u00a0During the three months ended April 30, 2020, the Company recognized stock-based expense related to its equity plans for employees and non-employee directors of $504 million. The aggregate stock compensation remaining to be recognized as of April 30, 2020 is as follows (in millions):Fiscal Period:Remaining nine months of fiscal 2021$1,638\u00a0Fiscal 20221,684\u00a0Fiscal 20231,219\u00a0Fiscal 2024630\u00a0Fiscal 202594\u00a0Thereafter3\u00a0Total stock compensation$5,268\u00a0The aggregate stock compensation remaining to be recognized to costs and expenses will be recognized over a weighted-average period of approximately 2 years. Shares reserved and available for future issuance as of April 30, 2020 and January 31, 2020 were 115\u00a0million shares and 133\u00a0million shares, respectively.", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Options Outstanding", "", "", "", "OutstandingStockOptions(in millions)", "", "Weighted-AverageExercise\u00a0Price", "", "AggregateIntrinsic Value (in millions)", "Balance as of January 31, 2020", "", "", "27", "", "", "$", "98.56", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Options granted under all plans", "", "", "6", "", "", "154.23", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Exercised", "", "", "(2)", "", "", "62.67", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Balance as of April 30, 2020", "", "", "31", "", "", "$", "111.82", "", "", "$", "1,542", "", "Vested or expected to vest", "", "", "28", "", "", "$", "108.78", "", "", "$", "1,509", "", "Exercisable as of April 30, 2020", "", "", "14", "", "", "$", "77.73", "", "", "$", "1,201", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Options Outstanding", "", "Options Exercisable", "Range of ExercisePrices", "", "NumberOutstanding(in millions)", "", "Weighted-AverageRemainingContractual\u00a0Life(Years)", "", "Weighted-AverageExercisePrice", "", "Number ofShares(in millions)", "", "Weighted-AverageExercisePrice", "$0.36 to $59.34", "", "7", "", "", "2.9", "", "$", "40.47", "", "", "6", "", "", "$", "41.91", "", "$59.37 to $80.99", "", "5", "", "", "3.4", "", "77.03", "", "", "4", "", "", "77.85", "", "$81.02 to $118.04", "", "5", "", "", "4.8", "", "114.30", "", "", "2", "", "", "113.29", "", "$122.03 to $148.95", "", "2", "", "", "6.0", "", "142.32", "", "", "0", "", "", "0.00", "", "$154.14", "", "6", "", "", "7.0", "", "154.14", "", "", "0", "", "", "0.00", "", "$155.20 to $189.50", "", "6", "", "", "5.8", "", "161.90", "", "", "2", "", "", "161.50", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "31", "", "", "4.9", "", "$", "111.82", "", "", "14", "", "", "$", "77.73", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "Restricted Stock\u00a0Outstanding", "", "Outstanding(in millions)", "", "Weighted-Average Grant Date Fair Value", "", "AggregateIntrinsicValue (in millions)", "Balance as of January 31, 2020", "28", "", "", "$", "140.14", "", "", "", "Granted - restricted stock units and awards", "9", "", "", "155.92", "", "", "", "Granted - performance-based stock units", "1", "", "", "154.14", "", "", "", "Canceled", "(1)", "", "", "138.87", "", "", "", "Vested and converted to shares", "(4)", "", "", "135.70", "", "", "", "Balance as of April 30, 2020", "33", "", "", "$", "142.71", "", "", "$", "5,428", "", "Expected to vest", "29", "", "", "", "", "$", "4,654", "", "", "", "", "", "", "", "Fiscal Period:", "", "Remaining nine months of fiscal 2021", "$", "1,638", "", "Fiscal 2022", "1,684", "", "Fiscal 2023", "1,219", "", "Fiscal 2024", "630", "", "Fiscal 2025", "94", "", "Thereafter", "3", "", "Total stock compensation", "$", "5,268", ""], ["", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["", "", "", "Options Outstanding"], ["", "", "", "OutstandingStockOptions(in millions)", "", "Weighted-AverageExercise\u00a0Price", "", "AggregateIntrinsic Value (in millions)"], ["Balance as of January 31, 2020", "", "", "27", "", "", "$", "98.56", "", "", ""], ["", "", "", "", "", "", "", ""], ["", "", "", "", "", "", "", ""], ["", "", "", "", "", "", "", ""], ["", "", "", "", "", "", "", ""], ["Options granted under all plans", "", "", "6", "", "", "154.23", "", "", ""], ["", "", "", "", "", "", "", ""], ["", "", "", "", "", "", "", ""], ["", "", "", "", "", "", "", ""], ["Exercised", "", "", "(2)", "", "", "62.67", "", "", ""], ["", "", "", "", "", "", "", ""], ["", "", "", "", "", "", "", ""], ["Balance as of April 30, 2020", "", "", "31", "", "", "$", "111.82", "", "", "$", "1,542", ""], ["Vested or expected to vest", "", "", "28", "", "", "$", "108.78", "", "", "$", "1,509", ""], ["Exercisable as of April 30, 2020", "", "", "14", "", "", "$", "77.73", "", "", "$", "1,201", ""], ["", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["", "", "Options Outstanding", "", "Options Exercisable"], ["Range of ExercisePrices", "", "NumberOutstanding(in millions)", "", "Weighted-AverageRemainingContractual\u00a0Life(Years)", "", "Weighted-AverageExercisePrice", "", "Number ofShares(in millions)", "", "Weighted-AverageExercisePrice"], ["$0.36 to $59.34", "", "7", "", "", "2.9", "", "$", "40.47", "", "", "6", "", "", "$", "41.91", ""], ["$59.37 to $80.99", "", "5", "", "", "3.4", "", "77.03", "", "", "4", "", "", "77.85", ""], ["$81.02 to $118.04", "", "5", "", "", "4.8", "", "114.30", "", "", "2", "", "", "113.29", ""], ["$122.03 to $148.95", "", "2", "", "", "6.0", "", "142.32", "", "", "0", "", "", "0.00", ""], ["$154.14", "", "6", "", "", "7.0", "", "154.14", "", "", "0", "", "", "0.00", ""], ["$155.20 to $189.50", "", "6", "", "", "5.8", "", "161.90", "", "", "2", "", "", "161.50", ""], ["", "", "", "", "", "", "", "", "", "", ""], ["", "", "31", "", "", "4.9", "", "$", "111.82", "", "", "14", "", "", "$", "77.73", ""], ["", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", "", ""], ["", "Restricted Stock\u00a0Outstanding"], ["", "Outstanding(in millions)", "", "Weighted-Average Grant Date Fair Value", "", "AggregateIntrinsicValue (in millions)"], ["Balance as of January 31, 2020", "28", "", "", "$", "140.14", "", "", ""], ["Granted - restricted stock units and awards", "9", "", "", "155.92", "", "", ""], ["Granted - performance-based stock units", "1", "", "", "154.14", "", "", ""], ["Canceled", "(1)", "", "", "138.87", "", "", ""], ["Vested and converted to shares", "(4)", "", "", "135.70", "", "", ""], ["Balance as of April 30, 2020", "33", "", "", "$", "142.71", "", "", "$", "5,428", ""], ["Expected to vest", "29", "", "", "", "", "$", "4,654", ""], ["", "", "", "", "", ""], ["Fiscal Period:", ""], ["Remaining nine months of fiscal 2021", "$", "1,638", ""], ["Fiscal 2022", "1,684", ""], ["Fiscal 2023", "1,219", ""], ["Fiscal 2024", "630", ""], ["Fiscal 2025", "94", ""], ["Thereafter", "3", ""], ["Total stock compensation", "$", "5,268", ""]]}]